Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 361-363 , July 2008

Familial pheochromocytoma

  • Mary A. Bissada, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    • ,
  • Ahmed S. Safwat, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    • ,
  • Raouf M. Seyam, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    • ,
  • Saif Al Sobhi, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    • ,
  • Kamal A. Hanash, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    • ,
  • Nabil K. Bissada, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-501-686-5241; fax: +1-501-686-5277.

Received 21 February 2007 ,Revised 22 March 2007 ,Accepted 22 March 2007.

References 

  1. Tank ES, Gelbard MK, Blank B. Familial pheochromocytomas. J Urol. 1982;128:1013–1016
  2. O'Connor DT. The adrenal medulla, catecholamines, and pheochromocytoma. In:  Goldman L,  Ausiello D editor. Cecil Textbook of Medicine. 22nd ed.. Philadelphia: W.B. Saunders; 2004;p. 1419–1424
  3. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma (Review of a 50-year autopsy series). Mayo Clin Proc. 1981;56:354–360
  4. Steiner AL, Goodman AD, Powers SR. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism, and Cushing's disease; multiple endocrine neoplasia, Type 2. Medicine. 1968;47:371–409
  5. Schinike RN, Hartmann WH, Prout TE, et al. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas (A possible regulatory defect in the differentiation of chromaffin tissue). N Engl J Med. 1968;279:1–7
  6. Ponder BA, Ponder MA, Coffey R, et al. Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet. 1988;1:397–401
  7. Nguyen L, Niccoli-Sire P, Caron P, et al. Pheochromocytoma in multiple endocrine neoplasia type 2: A prospective study. Eur J Endocrinol. 2001;144:37–44
  8. Yip L, Lee JE, Shapiro SE, et al. Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004;198:525–535
  9. Patocs A, Karadi E, Toth M, et al. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: An analysis of 41 cases investigated in a single endocrine centre. Eur J Cancer Prev. 2004;13:403–409
  10. Walz MK, Alesina PF, Wenger FA, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patients. World J Surg. 2006;30:899–908

PII: S1078-1439(07)00088-9

doi: 10.1016/j.urolonc.2007.03.025

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 361-363 , July 2008

Article Tools